Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: 18F-fluorocholine PET/CT Imaging in Hyperparathyroidism [NA]
This clinical trial update reports on a study evaluating 18F-fluorocholine PET/CT imaging for hyperparathyroidism, sponsored by the Universi…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass [NA]
This clinical trial update notes the completion of a study investigating the optimal calcium supplement after Roux-en-Y gastric bypass in pa…
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: the Study on Prognostic for Hemodialysis Patients
Clinical trial update for a study on prognosis in hemodialysis patients focusing on secondary hyperparathyroidism. The status/result details…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Genetic Evaluation of Families With Endocrine Cancers
This completed clinical trial evaluates genetic factors in families with endocrine cancers, including pancreatic cancer, thymic carcinoma, h…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients. [NA]
A completed clinical trial evaluating the effectiveness of oral alfacalcidol for secondary hyperparathyroidism in patients on chronic hemodi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation
A completed clinical trial update analyzing bone microarchitecture using HR-pQCT in patients with chronic kidney disease who are candidates …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism [NA]
A randomized trial comparing surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism has completed.
-
FDA approval · 2017-05-23FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for Sensipar (cinacalcet hydrochloride) from Amgen Inc, relating to labeling changes for the drug.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients [Phase 4]
A Phase 4 pilot trial evaluated whether lowering parathyroid hormone reduces erythropoietin consumption in calcitriol-resistant patients wit…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Minimally Invasive Radioguided Parathyroidectomy
This clinical trial update reports the completion of a study evaluating minimally invasive radioguided parathyroidectomy for primary hyperpa…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy
A completed clinical trial sponsored by Benha University investigating how common secondary hyperparathyroidism is among patients with diabe…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
A pilot study evaluating hypovitaminosis D, hyperparathyroidism, and hypomagnesemia in congestive heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism [Phase 2]
Phase 2 study results for etelcalcetide in hemodialysis patients with secondary hyperparathyroidism, evaluating safety, tolerability and eff…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism [Phase 2]
Open-label Phase 2 trial assessing the long-term safety and efficacy of etelcalcetide in secondary hyperparathyroidism has been terminated. …
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder [Phase 2]
Phase 2 results update for etelcalcetide in treating secondary hyperparathyroidism in hemodialysis patients with CKD-MBD. Results were poste…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease [NA]
Clinical trial update on FGF-23 regulation in chronic kidney disease with results posted; focus on secondary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid [Phase 4]
Phase 4 clinical trial of REGPARA (cinacalcet) in dialysis patients with secondary hyperparathyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis [Phase 3]
Phase 3 trial assessing efficacy and safety of etelcalcetide (AMG 416) for secondary hyperparathyroidism in chronic kidney disease patients …
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Phase 3 Study of KHK7580 [Phase 2, Phase 3]
This update announces completion of the Phase 2/Phase 3 clinical trial of KHK7580 for secondary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery [Phase 3]
A Phase 3 trial evaluated paricalcitol plus cholecalciferol for secondary hyperparathyroidism in patients after Roux-en-Y gastric bypass; th…
-
FDA approval · 2017-03-09FDA Approved: PARICALCITOL — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original ANDA for PARICALCITOL, a generic paricalcitol product for treating secondary hyperparathy…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism [Phase 3]
Phase 3 intra-individual titration trial evaluating KRN1493 for treating hypercalcemia in patients with parathyroid carcinoma or intractable…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating KHK7580 for secondary hyperparathyroidism in patients receiving hemodialysis has completed. The sponsor is Kyow…
-
EMA approval · 2017-02-24First hormone replacement therapy for parathyroid disorder
The European Medicines Agency announces the first hormone replacement therapy for a parathyroid disorder, marking a new treatment option.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism
This study evaluated whether the serum calcium to phosphorus ratio (Ca/P) can serve as a simple, inexpensive screening test to diagnose prim…